Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new details about a study on Relapsing Multiple Sclerosis (RMS), specifically mentioning the EudraCT number and the revision version. However, significant content regarding the study's objectives, inclusion and exclusion criteria, and previous revision details has been removed.SummaryDifference7%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check89 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check96 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.